Myosin 9 antibody (C-Term)
Quick Overview for Myosin 9 antibody (C-Term) (ABIN7464469)
Target
See all Myosin 9 (MYH9) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Human, Mouse
-
Purification
- Affinity purified by Protein A.
-
Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human MYH9. The exact sequence is proprietary.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: HeLa , MYH9-transfected 293T , Neuro2A , C8D30 , NIH-3T3 , Raw264.7 , C2C12
Validation: Overexpression
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, No Preservative
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Myosin 9 (MYH9)
-
Alternative Name
- myosin heavy chain 9
-
Background
- Myosin heavy chain 9 , BDPLT6 , DFNA17 , EPSTS , FTNS , MATINS , MHA , NMHC-II-A , NMMHC-IIA , NMMHCA,This gene encodes a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq]
-
Molecular Weight
- 227 kDa
-
Gene ID
- 4627
-
UniProt
- P35579
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex
Target
-